Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
RESEARCH TOOLSreports
Holding TMCI?
Track your performance easily
TMCI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.92 - $15.98
Previous Close$8.29
Volume686.54K
Average Volume (3M)600.70K
Market Cap
$516.44M
Enterprise Value$503.36M
Total Cash (Recent Filing)$82.80M
Total Debt (Recent Filing)$69.72M
Price to Earnings (P/E)―
Beta2.00
Next Earnings
Feb 26, 2025EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding62,297,078
10 Day Avg. Volume1,133,582
30 Day Avg. Volume600,704
Standard Deviation0.16
R-Squared0.00514
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.79
Price to Sales (P/S)2.55
Price to Cash Flow (P/CF)-10.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.48
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-10.44
Forecast
1Y Price Target
$7.50Price Target Upside-6.72% Downside
Rating ConsensusHold
Number of Analyst Covering4
Treace Medical Concepts News
PremiumCompany Announcements
Treace Medical Concepts Reports Strong Q3 2024 Growth
Ownership Overview
28.98% Insiders
11.02% Mutual Funds
9.37% Other Institutional Investors
37.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMCI FAQ
What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $3.92 and its highest was $15.98 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Currently, no data Available
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s upcoming earnings report date is Feb 26, 2025 which is in 104 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on Nov 05, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.272 by $0.022.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Overvalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -$0.04.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 62,297,077 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.272. Following the earnings report the stock price went up 35.069%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Among the largest hedge funds holding Treace Medical Concepts’s share is Bridgewater Associates, LP. It holds Treace Medical Concepts’s shares valued at N/A.
---
Treace Medical Concepts Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.50 (-6.72% Downside)
$7.50 (-6.72% Downside)
Blogger Sentiment
Bearish
TMCI Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.1%
Last 30 Days ▲ 17.8%
Last 30 Days ▲ 17.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.49%
12-Months-Change
Fundamentals
Return on Equity
-50.69%
Trailing 12-Months
Asset Growth
-11.41%
Trailing 12-Months
Company Description
Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly.
---
TMCI Earnings Call
Q3 2024
0:00 / 0:00
---
TMCI Stock 12 Month Forecast
Average Price Target
$7.50
▼(-6.72% Downside)
Technical Analysis
---